https://old.international-pharma.com/abzena-appoints-giovanni-escobar-as-svp-and-site-head-of-bristol-pennsylvania-operations/ 2020-10-06T08:26:15+00:00 https://old.international-pharma.com/natoli-engineering-announces-tablet-press-included-in-new-diosna-dierks-sohne-gmbh-processlab/ 2020-10-06T08:07:43+00:00 https://old.international-pharma.com/full-cphi-pharmapack-europe-schedule-returns-in-2021-with-live-hybrid-events/ 2020-10-06T07:56:05+00:00 https://old.international-pharma.com/vialex-long-term-study-confirms-improved-surface-durability/ 2020-10-05T14:01:40+00:00 https://old.international-pharma.com/best-practice-in-sample-identification-solutions/ 2020-10-05T13:04:49+00:00 https://old.international-pharma.com/wp-content/uploads/2020/10/Picture1.jpg https://old.international-pharma.com/nhs-england-report-identifies-need-for-radical-change-in-diagnostic-services/ 2020-10-05T12:38:44+00:00 https://old.international-pharma.com/kyowa-kirins-crysvita-wins-eu-approval-for-expanded-xlh-population/ 2020-10-05T12:37:07+00:00 https://old.international-pharma.com/bms-opdivo-plus-yervoy-misses-the-mark-in-high-risk-melanoma/ 2020-10-05T12:35:50+00:00 https://old.international-pharma.com/janssen-meiragtx-showcase-nine-month-data-for-sight-loss-gene-therapy/ 2020-10-05T12:33:55+00:00 https://old.international-pharma.com/lonza-launches-the-pyrocell-monocyte-activation-test-system-for-reliable-and-sustainable-in-vitro-pyrogen-testing/ 2020-10-05T11:47:03+00:00 https://old.international-pharma.com/cobra-biologics-selected-to-manufacture-plasmids-for-phase-i-clinical-trial-of-scancells-covid-19-vaccine-in-2021/ 2020-10-05T11:45:23+00:00 https://old.international-pharma.com/mackwell-solutions-signs-partnership-deal-with-medi-immune/ 2020-10-05T11:43:33+00:00 https://old.international-pharma.com/inceptua-receives-approval-of-marketing-authorization-transfer-of-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion/ 2020-10-05T11:41:37+00:00 https://old.international-pharma.com/fujifilm-wako/ 2020-10-02T12:30:52+00:00 https://old.international-pharma.com/wp-content/uploads/2020/10/FFW_ColorKY_2020.jpg https://old.international-pharma.com/wp-content/uploads/2020/10/FFW_ESF_Plate_2020.jpg https://old.international-pharma.com/aptar-pharma-to-unveil-its-state-of-the-art-virtual-booth-at-cphi-festival-of-pharma-platinum-sponsor-and-finalist-for-four-cphi-pharma-awards/ 2020-10-01T14:08:40+00:00 https://old.international-pharma.com/wp-content/uploads/2020/10/Aptar.jpg https://old.international-pharma.com/vertex-crispr-therapeutics-sickle-cell-gene-therapy-wins-prime-designation/ 2020-09-24T09:53:19+00:00 https://old.international-pharma.com/owlstone-medicals-breath-biopsy-test-improves-detection-of-liver-disease/ 2020-09-24T09:52:16+00:00 https://old.international-pharma.com/digital-tech-has-health-benefits-for-dementia-patients-project-finds/ 2020-09-24T09:51:14+00:00 https://old.international-pharma.com/fda-and-ema-accept-regulatory-submissions-for-ucbs-bimekizumab/ 2020-09-24T09:47:13+00:00 https://old.international-pharma.com/verona-pharma-launches-late-stage-copd-trial-programme/ 2020-09-24T09:45:59+00:00 https://old.international-pharma.com/oncimmune-partners-with-genentech-to-profile-samples-from-rheumatology-trials/ 2020-09-24T09:44:54+00:00 https://old.international-pharma.com/keytruda-lenvima-combo-shows-promise-in-hard-to-treat-cancers/ 2020-09-23T08:43:59+00:00 https://old.international-pharma.com/uks-chief-medical-officers-upgrade-coronavirus-alert-level/ 2020-09-23T08:42:10+00:00 https://old.international-pharma.com/gsks-zejula-and-azs-lynparza-leap-toward-broader-eu-approval/ 2020-09-23T08:38:29+00:00 https://old.international-pharma.com/roche-acquires-irish-biotech-firm-inflazome/ 2020-09-23T08:37:46+00:00 https://old.international-pharma.com/bristol-myers-squibbs-opdivo-shows-benefit-in-oesophageal-cancers/ 2020-09-23T08:36:17+00:00 https://old.international-pharma.com/2025-will-see-cell-and-gene-therapy-capacity-shortages-in-the-usa-and-10-mab-approvals-in-china/ 2020-09-23T08:34:06+00:00 https://old.international-pharma.com/new-laboratory-and-regulatory-services-for-biotech-customers/ 2020-09-21T09:50:59+00:00 https://old.international-pharma.com/az-pauses-covid-19-vaccine-trials-for-safety-review/ 2020-09-16T10:47:31+00:00 https://old.international-pharma.com/nice-turns-down-celgenes-revlimid-as-multiple-myeloma-maintenance-treatment/ 2020-09-16T10:39:44+00:00 https://old.international-pharma.com/nice-unites-with-global-health-leaders-to-highlight-evidence-based-healthcare/ 2020-09-16T10:38:04+00:00 https://old.international-pharma.com/a-third-of-uk-doctors-have-treated-covid-19-patients-without-full-ppe-report-finds/ 2020-09-16T10:36:11+00:00 https://old.international-pharma.com/icr-study-combines-precision-medicines-to-treat-drug-resistant-cancers/ 2020-09-16T10:34:16+00:00 https://old.international-pharma.com/sleep-apnoea-linked-to-poorer-outcomes-from-covid-19-study-finds/ 2020-09-16T10:32:11+00:00 https://old.international-pharma.com/a-covid-19-vaccine-in-early-november-extremely-unlikely-but-not-impossible-warp-speed-head-slaoui/ 2020-09-09T08:26:30+00:00 https://old.international-pharma.com/akebia-crashes-on-vadadustat-flop-in-larger-anemia-indication-will-az-fibrogen-own-the-market/ 2020-09-09T08:25:06+00:00 https://old.international-pharma.com/roche-blueprint-take-on-lilly-with-fda-approval-for-ret-cancer-drug-gavreto/ 2020-09-09T08:22:59+00:00 https://old.international-pharma.com/csl-plots-millions-of-doses-of-covid-19-vaccine-shots-including-astrazenecas-for-aussie-government/ 2020-09-09T08:20:56+00:00 https://old.international-pharma.com/former-fda-commissioner-dr-scott-gottlieb-to-address-industry-on-sustainable-innovation-at-cphi-festival-of-pharma/ 2020-09-09T08:17:02+00:00 https://old.international-pharma.com/uk-launch-for-novos-new-diabetes-pill/ 2020-09-02T12:42:31+00:00 https://old.international-pharma.com/kevzara-fails-in-phiii-covid-19-trial/ 2020-09-02T12:40:49+00:00 https://old.international-pharma.com/roche-to-launch-sars-cov-2-rapid-antigen-test/ 2020-09-02T12:38:29+00:00 https://old.international-pharma.com/bms-bags-us-approval-for-onureg/ 2020-09-02T12:37:05+00:00 https://old.international-pharma.com/nice-green-light-for-immunotherapy-bavencio/ 2020-09-02T12:35:52+00:00 https://old.international-pharma.com/eu-oks-paediatric-use-of-gileads-epclusa/ 2020-09-02T12:34:31+00:00 https://old.international-pharma.com/stoelzle-pursues-their-path-towards-establishing-sustainably-long-term-success/ 2020-08-26T13:54:24+00:00 https://old.international-pharma.com/jj-to-acquire-momenta-for-6-5-billion/ 2020-08-26T08:52:20+00:00 https://old.international-pharma.com/clinical-research-cut-87-at-peak-of-pandemic/ 2020-08-26T08:50:43+00:00 https://old.international-pharma.com/novartis-cml-drug-hits-phiii-targets/ 2020-08-26T08:49:36+00:00 https://old.international-pharma.com/no-increased-risk-from-covid-19-for-healthy-pregnant-women/ 2020-08-26T08:41:53+00:00 https://old.international-pharma.com/abbvie-submits-rinvoq-for-ankylosing-spondylitis/ 2020-08-26T08:38:37+00:00 https://old.international-pharma.com/takeda-signs-deal-with-uk-biotech-engitix/ 2020-08-26T08:36:17+00:00 https://old.international-pharma.com/acg-promotes-susheel-pillai-as-the-new-ceo-for-inspection-business/ 2020-08-25T15:01:53+00:00 https://old.international-pharma.com/wp-content/uploads/2020/08/c6e2cffc-4423-406c-a73f-6f51b2582bfa-1.jpg https://old.international-pharma.com/europital-forecast-30-cagr-from-uk-biotech-for-three-years/ 2020-08-24T14:35:05+00:00 https://old.international-pharma.com/eu-regulators-to-review-evrysdi-for-sma/ 2020-08-19T09:06:06+00:00 https://old.international-pharma.com/hancock-confirms-replacement-of-public-health-england/ 2020-08-19T09:04:29+00:00 https://old.international-pharma.com/gov-announces-expansion-of-uks-ons-covid-19-survey/ 2020-08-19T09:03:38+00:00 https://old.international-pharma.com/priority-review-for-imfinzis-less-frequent-dosing-regimen/ 2020-08-19T09:02:27+00:00 https://old.international-pharma.com/verona-progresses-phii-trial-of-copd-inhaler/ 2020-08-19T09:01:23+00:00 https://old.international-pharma.com/roches-enspryng-approved-for-neuromyelitis-optica-spectrum-disorder/ 2020-08-19T08:58:23+00:00 https://old.international-pharma.com/eli-lilly-pieris-collaborate-on-her2-positive-cancer-clinical-programme/ 2020-08-12T08:52:01+00:00 https://old.international-pharma.com/destiny-pharmas-novel-antibiotic-asset-clears-safety-review/ 2020-08-12T08:51:20+00:00 https://old.international-pharma.com/bayer-expands-womens-health-pipeline-with-kandy-acquisition/ 2020-08-12T08:50:08+00:00 https://old.international-pharma.com/gilead-aims-for-approval-of-covid-19-drug-remdesivir-in-the-us/ 2020-08-12T08:49:12+00:00 https://old.international-pharma.com/demand-for-mental-health-services-to-rise-due-to-covid-19-report-finds/ 2020-08-12T08:48:16+00:00 https://old.international-pharma.com/bms-opdivo-improves-survival-in-gastric-and-oesophageal-cancers/ 2020-08-12T08:47:09+00:00 https://old.international-pharma.com/pharmalex-strengthens-its-commercial-organization/ 2020-08-10T08:25:53+00:00 https://old.international-pharma.com/uk-firm-starts-research-on-skin-patch-for-covid-vaccines/ 2020-08-05T08:49:19+00:00 https://old.international-pharma.com/janssens-depression-nasal-spray-spravato-bags-new-fda-approval/ 2020-08-05T08:48:05+00:00 https://old.international-pharma.com/nhs-adapts-to-pandemic-with-covid-friendly-cancer-treatments/ 2020-08-05T08:46:36+00:00 https://old.international-pharma.com/astrazeneca-forges-licensing-agreement-with-redx-pharma/ 2020-08-05T08:45:39+00:00 https://old.international-pharma.com/pharmas-reputation-has-climbed-during-covid-19-pandemic-study-finds/ 2020-08-05T08:44:44+00:00 https://old.international-pharma.com/novartis-car-t-therapy-kymriah-hits-endpoint-in-follicular-lymphoma-trial/ 2020-08-05T08:42:07+00:00 https://old.international-pharma.com/reaping-the-rewards-of-structured-content-management-in-rd-regulatory-operations-preparation-is-everything/ 2020-08-03T15:09:06+00:00 https://old.international-pharma.com/cphi-japan-rescheduled-for-spring-2021-with-digital-solutions-to-be-launched/ 2020-07-29T08:51:05+00:00 https://old.international-pharma.com/people-at-high-risk-of-diabetes-fast-tracked-into-prevention-programme/ 2020-07-29T08:49:50+00:00 https://old.international-pharma.com/gov-unveils-new-anti-obesity-measures/ 2020-07-29T08:48:56+00:00 https://old.international-pharma.com/sobi-to-refile-gamifant-following-chmp-rejection/ 2020-07-29T08:47:55+00:00 https://old.international-pharma.com/az-farxiga-hits-all-goals-in-chronic-kidney-disease-trial/ 2020-07-29T08:46:17+00:00 https://old.international-pharma.com/new-research-to-investigate-higher-covid-19-risk-among-bame-groups/ 2020-07-29T08:45:08+00:00 https://old.international-pharma.com/ec-approves-subcutaneous-version-of-remsima/ 2020-07-29T08:43:15+00:00 https://old.international-pharma.com/uk-launch-for-ajovy-injector-pen/ 2020-07-22T10:08:32+00:00 https://old.international-pharma.com/uclb-apollo-secure-first-licensing-deal-with-us-investment-powerhouse/ 2020-07-22T10:07:41+00:00 https://old.international-pharma.com/trainee-gp-numbers-rise-for-third-year-running/ 2020-07-22T10:06:49+00:00 https://old.international-pharma.com/new-data-shows-steep-rise-in-people-waiting-for-cancer-tests/ 2020-07-22T10:05:59+00:00 https://old.international-pharma.com/bms-rolls-cancer-survivor-campaign-with-tv-actor-spokesman-and-a-new-mission/ 2020-07-22T10:05:09+00:00 https://old.international-pharma.com/astrazeneca-scores-speedy-fda-review-for-farxiga-based-on-innovative-heart-attack-trial-design/ 2020-07-22T10:03:29+00:00 https://old.international-pharma.com/tecentriq-misses-mark-in-ovarian-cancer-trial/ 2020-07-15T10:05:19+00:00 https://old.international-pharma.com/uk-report-finds-low-awareness-of-non-melanoma-skin-cancer/ 2020-07-15T10:01:51+00:00 https://old.international-pharma.com/study-indicates-lockdown-significantly-reduced-coronavirus/ 2020-07-15T09:51:54+00:00 https://old.international-pharma.com/radiotherapy-in-fewer-doses-safe-for-early-breast-cancer/ 2020-07-15T09:49:09+00:00 https://old.international-pharma.com/fda-committee-backs-gsks-multiple-myeloma-drug/ 2020-07-15T09:47:34+00:00 https://old.international-pharma.com/janssens-tremfya-wins-psoriatic-arthritis-approval/ 2020-07-15T09:45:22+00:00 https://old.international-pharma.com/cr-uk-pairs-with-abcam/ 2020-07-08T09:37:14+00:00 https://old.international-pharma.com/regeneron-kicks-off-phase-iii-trial-of-covid-19-antibody-cocktail/ 2020-07-08T09:36:24+00:00 https://old.international-pharma.com/eu-nod-for-lynparza-in-pancreatic-cancer/ 2020-07-08T09:35:18+00:00 https://old.international-pharma.com/gsk-links-with-medicago-to-develop-novel-covid-19-vaccine/ 2020-07-08T09:34:09+00:00 https://old.international-pharma.com/new-clinical-trial-platform-launched-to-accelerate-covid-19-treatments/ 2020-07-08T09:33:22+00:00 https://old.international-pharma.com/kings-researchers-win-1m-grant-for-covid-19-research/ 2020-07-08T09:32:26+00:00 https://old.international-pharma.com/cphi-festival-of-pharma-to-support-and-lead-global-pharma-industry-forward-with-new-digital-experience-in-2020/ 2020-07-01T13:22:20+00:00 https://old.international-pharma.com/cr-uk-calls-on-scottish-gov-to-urgently-restart-cancer-trials/ 2020-07-01T09:33:46+00:00 https://old.international-pharma.com/pfizer-links-with-sidekickhealth-for-digital-health-solution/ 2020-07-01T09:32:46+00:00 https://old.international-pharma.com/cambridge-spin-out-pharmenable-raises-1-8m-for-drug-discovery/ 2020-07-01T09:31:44+00:00 https://old.international-pharma.com/vertex-signs-landmark-deal-with-nhs-for-cf-therapy/ 2020-07-01T09:30:29+00:00 https://old.international-pharma.com/cma-imposes-1-2m-fines-for-price-fixing-in-private-eye-care/ 2020-07-01T09:29:01+00:00 https://old.international-pharma.com/us-approves-bavencio-for-bladder-cancer/ 2020-07-01T09:28:01+00:00 https://old.international-pharma.com/final-nice-green-light-for-janssens-stelara-in-uc/ 2020-06-17T12:16:04+00:00 https://old.international-pharma.com/gsk-and-ideaya-partner-in-synthetic-lethality/ 2020-06-17T12:14:00+00:00 https://old.international-pharma.com/mhra-suspends-covid-19-hydroxychloroquine-trials/ 2020-06-17T12:10:17+00:00 https://old.international-pharma.com/dexamethasone-cut-deaths-by-35-in-ventilated-covid-19-patients/ 2020-06-17T12:04:39+00:00 https://old.international-pharma.com/jazz-small-cell-lung-cancer-therapy-wins-us-green-light/ 2020-06-17T12:02:45+00:00 https://old.international-pharma.com/ert-acquires-apdm-wearable-technologies-to-reinvent-endpoint-measurement-in-clinical-trials/ 2020-06-11T10:25:19+00:00 https://old.international-pharma.com/wuxi-biologics-inks-lease-agreement-for-3rd-u-s-facility-in-global-expansion-push/ 2020-06-10T09:13:29+00:00 https://old.international-pharma.com/is-covid-19-changing-how-biopharmas-think-of-ma-not-really-say-jj-and-takeda-execs/ 2020-06-10T09:10:30+00:00 https://old.international-pharma.com/fujifilm-plots-928m-infusion-at-danish-biologics-plant-to-double-production-capacity/ 2020-06-10T09:02:51+00:00 https://old.international-pharma.com/sanofis-sarclisa-rejected-by-nice-over-uncertainties-on-total-benefit-cost-effectiveness/ 2020-06-10T08:57:42+00:00 https://old.international-pharma.com/italys-flamma-quadruples-rd-space-to-support-api-production-in-u-s/ 2020-06-10T08:55:24+00:00 https://old.international-pharma.com/ecolab-complete-their-low-residue-line-up/ 2020-06-08T08:44:23+00:00 https://old.international-pharma.com/wp-content/uploads/2020/06/Wall-Mopping_Pre-imprenated-Wipe_Blue-Mop-Head_CMYK.jpg https://old.international-pharma.com/new-us-approval-for-az-brilinta/ 2020-06-03T08:41:09+00:00 https://old.international-pharma.com/roches-tecentriq-avastin-combo-wins-us-approval/ 2020-06-03T08:37:57+00:00 https://old.international-pharma.com/sanofis-sarclisa-cleared-in-europe-for-multiple-myeloma/ 2020-06-03T08:36:18+00:00 https://old.international-pharma.com/abbvie-files-rinvoq-for-psoriatic-arthritis/ 2020-06-03T08:34:48+00:00 https://old.international-pharma.com/abbott-launches-covid-19-lab-based-antibody-test/ 2020-05-20T10:08:34+00:00 https://old.international-pharma.com/roche-partners-with-vividion-on-novel-e3-ligases/ 2020-05-20T10:07:02+00:00 https://old.international-pharma.com/eu-approves-novartis-sma-gene-therapy-zolgensma/ 2020-05-20T10:00:51+00:00 https://old.international-pharma.com/covid-19-related-delays-to-cancer-treatment-could-cost-thousands-of-lives-research-shows/ 2020-05-20T09:59:13+00:00 https://old.international-pharma.com/new-partnership-to-sequence-human-genomes-in-fight-against-coronavirus/ 2020-05-13T10:32:00+00:00 https://old.international-pharma.com/over-50s-covid-19-trial-launches-across-uk/ 2020-05-13T10:29:40+00:00 https://old.international-pharma.com/nice-final-guidance-backs-pfizers-lorviqua/ 2020-05-13T10:26:41+00:00 https://old.international-pharma.com/oxford-biomedica-bags-mhra-nod-for-two-manufacturing-suites/ 2020-05-13T10:20:41+00:00 https://old.international-pharma.com/fast-track-for-modernas-novel-coronavirus-vaccine/ 2020-05-13T09:34:05+00:00 https://old.international-pharma.com/sanofi-and-regenerons-i-o-med-libtayo-on-a-roll-puts-up-basal-cell-carcinoma-win/ 2020-05-06T10:36:05+00:00 https://old.international-pharma.com/regeneron-scales-up-manufacturing-eyes-human-tests-of-covid-19-antibody-cocktail-in-june/ 2020-05-06T10:32:11+00:00 https://old.international-pharma.com/with-the-world-waiting-roche-socks-459m-into-covid-19-antibody-test-production/ 2020-05-06T10:28:39+00:00 https://old.international-pharma.com/novartis-incyte-will-take-jakafi-into-2nd-trial-for-covid-19-patients-on-ventilators/ 2020-05-06T10:24:56+00:00 https://old.international-pharma.com/turkish-cargo-achieved-the-highest-growth-rate-among-the-top-25-air-cargo-carriers/ 2020-05-06T10:17:40+00:00 https://old.international-pharma.com/roches-risdiplam-shows-promise-in-type-1-sma/ 2020-04-29T10:40:35+00:00 https://old.international-pharma.com/blueprints-ayvakit-fails-to-best-bayers-stivarga/ 2020-04-29T10:38:50+00:00 https://old.international-pharma.com/new-system-for-capturing-covid-19-death-toll-in-england/ 2020-04-29T10:37:15+00:00 https://old.international-pharma.com/national-cancer-director-urges-public-to-get-symptoms-checked-during-pandemic/ 2020-04-29T10:06:33+00:00 https://old.international-pharma.com/acg-continues-production-to-meet-mission-critical-pharmaceutical-requirements-in-tackling-covid-19-with-employee-safety-a-top-priority-across-its-operations/ 2020-04-28T14:02:28+00:00 https://old.international-pharma.com/opdivo-cabometyx-combo-hits-targets-in-first-line-kidney-cancer/ 2020-04-22T09:36:14+00:00 https://old.international-pharma.com/novartis-to-test-hydroxychloroquine-for-coronavirus/ 2020-04-22T09:34:43+00:00 https://old.international-pharma.com/novartis-highlights-benefits-of-mayzent-in-ms/ 2020-04-22T09:33:25+00:00 https://old.international-pharma.com/bayer-partners-with-population-health-research-institute-on-covid-19-research/ 2020-04-22T09:24:33+00:00 https://old.international-pharma.com/ritedose-selects-chargepoint-technologys-transfer-solution-for-biomanufacturing-project/ 2020-04-21T09:22:12+00:00 https://old.international-pharma.com/wp-content/uploads/2020/04/AseptiSafe-Bio-2-scaled-1.jpg https://old.international-pharma.com/lilly-partners-with-nih-to-test-olumiant-in-patients-hospitalized-with-covid-19/ 2020-04-15T10:53:02+00:00 https://old.international-pharma.com/pharma-astrazeneca-merck-finally-grab-a-green-light-for-rare-disease-med-koselugo/ 2020-04-15T10:50:24+00:00 https://old.international-pharma.com/dec-group-announces-the-acquisition-of-inno4life/ 2020-04-15T10:48:07+00:00 https://old.international-pharma.com/astrazeneca-to-test-blood-cancer-drug-calquence-in-covid-19-after-nih-sees-some-clinical-benefit/ 2020-04-15T10:45:51+00:00 https://old.international-pharma.com/bioquells-rapid-bio-decontamination-service-rbds-is-effective-against-coronavirus/ 2020-04-14T09:14:01+00:00 https://old.international-pharma.com/emirates-sky-cargo/ 2020-04-08T10:06:06+00:00 https://old.international-pharma.com/expanded-eu-approval-for-takedas-alunbrig/ 2020-04-08T09:02:29+00:00 https://old.international-pharma.com/oxford-biomedica-joins-consortium-for-promising-covid-19-vaccine/ 2020-04-08T08:59:57+00:00 https://old.international-pharma.com/challenges-of-drug-development-in-progressive-multiple-sclerosis/ 2020-04-01T13:26:17+00:00 https://old.international-pharma.com/outcome-health-ramps-efforts-to-help-pharma-with-covid-19-point-of-care-messaging/ 2020-04-01T09:44:11+00:00 https://old.international-pharma.com/astrazenecas-imfinzi-gets-fda-green-light-to-challenge-roche-in-small-cell-lung-cancer/ 2020-04-01T09:38:10+00:00 https://old.international-pharma.com/disaster-at-amarin-patent-loss-spurs-stock-spiral-but-all-hope-might-not-be-lost/ 2020-04-01T09:34:38+00:00 https://old.international-pharma.com/coronavirus-tracker-amgen-genfit-say-theyre-not-expecting-significant-trial-delays-though-others-might/ 2020-04-01T09:31:36+00:00 https://old.international-pharma.com/in-response-to-covid-19-acg-implements-work-from-home-policy-and-takes-other-progressive-measures-to-ensure-workforce-and-public-health/ 2020-03-27T16:03:39+00:00 https://old.international-pharma.com/with-its-cargo-operations-turkish-cargo-maintains-the-air-bridge-built-by-turkish-airlines/ 2020-03-25T10:07:27+00:00 https://old.international-pharma.com/covid-19-uk-clinical-tests-to-start-next-month-as-global-authorities-see-spike-in-unauthorised-meds/ 2020-03-25T09:54:42+00:00 https://old.international-pharma.com/covid-19-gilead-deals-with-overwhelming-remdesivir-demands-eli-lilly-halts-trial-enrolment/ 2020-03-25T09:52:41+00:00 https://old.international-pharma.com/venclexta-venclyxto-combo-extends-myeloid-leukaemia-survival/ 2020-03-25T09:50:05+00:00 https://old.international-pharma.com/life-sciences-innovation-on-the-rise-european-patent-office-reports-increase-in-patent-filings-in-2019/ 2020-03-23T16:36:44+00:00 https://old.international-pharma.com/wp-content/uploads/2020/03/Image-1-Growth-in-patent-applications.jpg https://old.international-pharma.com/wp-content/uploads/2020/03/Image-2-Top-applicants-Pharma.jpg https://old.international-pharma.com/wp-content/uploads/2020/03/Image-3-Top-applicants-Biotechnology.png https://old.international-pharma.com/owen-mumford-pharmaceutical-services/ 2020-03-23T13:57:09+00:00 https://old.international-pharma.com/pboa-members-committed-to-continuing-to-reliably-manufacture-drug-and-vaccine-products/ 2020-03-20T13:34:00+00:00 https://old.international-pharma.com/sanofi-joins-parade-of-drugmakers-pledging-no-covid-19-shortages/ 2020-03-18T10:05:57+00:00 https://old.international-pharma.com/lilly-and-boehringers-jardiance-chasing-az-nabs-speedy-fda-review-in-kidney-disease/ 2020-03-18T09:50:21+00:00 https://old.international-pharma.com/novartis-sidesteps-europe-travel-ban-to-provide-car-t-drug-kymriah-to-patients/ 2020-03-18T09:44:41+00:00 https://old.international-pharma.com/mercks-keytruda-pulled-from-englands-cancer-drugs-fund-in-bladder-cancer/ 2020-03-18T09:40:56+00:00 https://old.international-pharma.com/gene-change-could-cause-susceptibility-to-lung-disease/ 2020-03-11T09:27:38+00:00 https://old.international-pharma.com/tlx-cargo-launches-a-coronavirus-covid-19-viral-barrier-cargo-cover/ 2020-03-05T16:36:03+00:00 https://old.international-pharma.com/turkish-cargo-adds-quito-capital-of-ecuador-to-its-cargo-flight-network/ 2020-03-05T16:20:04+00:00 https://old.international-pharma.com/wp-content/uploads/2020/03/Turkish-Cargo-Quita-scaled.jpg https://old.international-pharma.com/woolcool-becomes-first-uk-pharma-packaging-company-to-achieve-b-corp-status/ 2020-03-05T10:49:50+00:00 https://old.international-pharma.com/coronavirus-spurs-india-to-restrict-exports-of-2-dozen-drugs/ 2020-03-04T10:11:31+00:00 https://old.international-pharma.com/eli-lilly-says-its-drug-supply-including-insulins-is-safe-from-covid-19-for-now/ 2020-03-04T10:05:31+00:00 https://old.international-pharma.com/international-research-partnership-and-edctp-to-invest-e44m-in-next-generation-antimalarials-to-combat-drug-resistant-malaria-in-africa/ 2020-03-04T09:57:38+00:00 https://old.international-pharma.com/keytruda-improves-pfs-in-classical-hodgkin-lymphoma/ 2020-03-04T09:37:08+00:00 https://old.international-pharma.com/merck-ceo-frazier-finds-fault-in-new-studies-suggesting-pharma-profits-are-too-high/ 2020-03-04T09:32:12+00:00 https://old.international-pharma.com/nemera-2/ 2020-03-03T15:50:03+00:00 https://old.international-pharma.com/wp-content/uploads/2020/03/Nemera_PutPatientsFirst.jpg https://old.international-pharma.com/wp-content/uploads/2020/03/Nemera_Picture1.png https://old.international-pharma.com/wp-content/uploads/2020/03/Nemera_Picture2.png https://old.international-pharma.com/proveris-scientific-testing-true-product-performance/ 2020-02-27T15:27:44+00:00 https://old.international-pharma.com/wp-content/uploads/2020/02/Proveris_Company-Profile-IPI2020_Proveris-Image_27Feb2020.jpg https://old.international-pharma.com/media-information-2020-2/ 2020-02-27T11:33:20+00:00 https://old.international-pharma.com/oxycontin-maker-purdue-pharma-launches-campaign-for-opioid-victims-to-file-claims/ 2020-02-26T09:53:45+00:00 https://old.international-pharma.com/chill-out-maintaining-the-pharma-cool-chain-in-hot-climates/ 2020-02-26T09:52:37+00:00 https://old.international-pharma.com/cocrystal-pharma-licences-coronavirus-drug-candidates/ 2020-02-26T09:42:17+00:00 https://old.international-pharma.com/sanofi-to-start-pharmaceutical-ingredients-company-which-it-says-may-avert-future-shortages/ 2020-02-26T09:37:17+00:00 https://old.international-pharma.com/turkish-cargo-continued-its-steady-growth-in-2019/ 2020-02-25T16:39:18+00:00 https://old.international-pharma.com/wp-content/uploads/2020/02/TurkishCargo-scaled.jpg https://old.international-pharma.com/datwyler-launches-neoflex-plungers-offering-superior-functionality-and-compatability/ 2020-02-25T15:42:16+00:00 https://old.international-pharma.com/wp-content/uploads/2020/02/Datwylers.png https://old.international-pharma.com/reich-insurance-launches-innovative-online-life-sciences-insurance-quote-portal/ 2020-02-25T14:15:16+00:00 https://old.international-pharma.com/almac-clinical-services-just-in-time-manufacturing-operations-pass-eu-regulatory-inspection/ 2020-02-25T13:17:10+00:00 https://old.international-pharma.com/chargepoint-technology/ 2020-02-20T16:54:10+00:00 https://old.international-pharma.com/wp-content/uploads/2020/02/AseptiSafe-Bio-1-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2020/02/ChargeBag-PE-S-6-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2020/02/Containment-2.png https://old.international-pharma.com/under-the-gun-acorda-slashes-inbrija-sales-forecast-amid-lackluster-launch/ 2020-02-19T09:57:47+00:00 https://old.international-pharma.com/gbt-takes-a-page-from-hiv-playbook-as-it-embarks-on-oxbryta-launch/ 2020-02-19T09:56:37+00:00 https://old.international-pharma.com/pharma-has-astrazeneca-lost-its-glow-drugmaker-misses-on-top-cancer-meds-braces-for-coronavirus/ 2020-02-19T09:52:18+00:00 https://old.international-pharma.com/fda-anticipates-disruptions-shortages-as-china-outbreak-plays-out/ 2020-02-19T09:46:00+00:00 https://old.international-pharma.com/kte-x19-bags-fda-priority-review-in-mantle-cell-lymphoma/ 2020-02-12T09:46:34+00:00 https://old.international-pharma.com/ukri-launches-nucleic-acid-therapy-accelerator/ 2020-02-12T09:45:44+00:00 https://old.international-pharma.com/cancer-vaccine-could-boost-immunotherapy-effectiveness/ 2020-02-12T09:44:52+00:00 https://old.international-pharma.com/new-score-developed-to-measure-multimorbidity/ 2020-02-12T09:39:39+00:00